Looking for a biopharma job in North Carolina? Check out the BioSpace list of seven companies hiring life sciences ...

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...

A new report found that 85% of pharma respondents are increasing their artificial intelligence investments, and 70% see AI as an immediate priority. Two experts discuss how biopharmas are implementing ...

Monarez is the first CDC director to be confirmed by the Senate under a new 2023 law and will be the first person without a ...

CEO Emma Walmsley maintained that continued investment in the U.S. is a priority for the pharma to ensure its medicines for ...

George Tidmarsh has only been at the Center for Drug Evaluation and Research for nine days, but will now add supervision of a ...

Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for ...

As analysts parsed news of Vinay Prasad’s ouster, worries over drug approval delays, cell and gene therapy impacts and more ...

Sarepta’s Elevidys is back on the market for ambulatory patients with Duchenne muscular dystrophy, Health Secretary Robert F. Kennedy Jr. reportedly plans to dissolve the U.S. Preventive Services Task ...

In a surprise double announcement Tuesday, Novo reduced sales guidance by 5%—attributing the change to slowed growth of its ...

Against steep odds and well-established paradigms, these four companies have successfully been commercializing their products ...

Though nerves abound for funders and founders in the industry, money continues to flow into startups, sometimes in ...